Phase II trial shows neurocognitive function decline but stable quality of life in first year after temozolomide-based chemoradiotherapy
A secondary analysis of the phase II clinical trial NRG-RTOG 0424, which initially reported a 73.1%…
Browsing: chemoradiotherapy
ASCO 2019: Suggested benefit in PCV chemoradiotherapy for both IDH-mutant WHO-defined molecular subgroups
A recent, updated predictive analysis of the three WHO-defined molecular subgroups based on isocitrate dehydrogenase…
ESMO 2018: Patients with HPV-positive oropharynx cancer should receive chemoradiation
Patients with human papilloma virus (HPV)-positive throat cancer should receive chemoradiotherapy rather than cetuximab with…
Pre-Operative Chemotherapy With Radiation May Help People With Pancreatic Cancer Live Longer
A randomized, phase III trial found that people who received chemotherapy with radiation (chemoradiotherapy) before…